Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.
Ann Oncol
; 25(11): 2147-2155, 2014 Nov.
Article
in En
| MEDLINE
| ID: mdl-25164908
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Nuclear Proteins
/
Antineoplastic Combined Chemotherapy Protocols
/
Carrier Proteins
/
Carcinoma, Non-Small-Cell Lung
/
BRCA1 Protein
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Year:
2014
Type:
Article